EXAGEN INC. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Exagen Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2024.
Exagen Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.66M, a 8.01% increase year-over-year.
Exagen Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$15.4M, a 52.1% increase year-over-year.
Exagen Inc. annual Operating Income (Loss) for 2023 was -$22.8M, a 50.4% increase from 2022.
Exagen Inc. annual Operating Income (Loss) for 2022 was -$46.1M, a 91.3% decline from 2021.
Exagen Inc. annual Operating Income (Loss) for 2021 was -$24.1M, a 58.5% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$15.4M	-$4.66M	+$406K	+8.01%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	-$15.8M	-$2.59M	+$2.33M	+47.4%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-05
Q1 2024	-$18.1M	-$3M	+$4.7M	+61%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	-$22.8M	-$5.15M	+$9.34M	+64.5%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-18
Q3 2023	-$32.2M	-$5.07M	+$2.75M	+35.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	-$34.9M	-$4.92M	+$9.15M	+65.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-05
Q1 2023	-$44.1M	-$7.71M	+$1.97M	+20.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q4 2022	-$46.1M	-$14.5M	-$8.24M	-132%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-18
Q3 2022	-$37.8M	-$7.82M	-$1.31M	-20.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$36.5M	-$14.1M	-$8.32M	-145%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-07
Q1 2022	-$28.2M	-$9.68M	-$4.11M	-73.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$24.1M	-$6.25M	-$3.49M	-127%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-20
Q3 2021	-$20.6M	-$6.5M	-$2.72M	-71.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-21
Q2 2021	-$17.9M	-$5.74M	-$2.33M	-68%	Apr 1, 2021	Jun 30, 2021	10-Q/A	2022-11-21
Q1 2021	-$15.5M	-$5.57M	-$346K	-6.63%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	-$15.2M	-$2.76M	+$97K	+3.39%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-22
Q3 2020	-$15.3M	-$3.79M	-$1.63M	-75.5%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$13.7M	-$3.42M	-$1.01M	-41.8%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	-$12.6M	-$5.22M	-$3.35M	-179%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	-$9.3M	-$2.86M			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-16
Q3 2019		-$2.16M	-$1.02M	-90.4%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-10
Q2 2019		-$2.41M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-28
Q1 2019		-$1.87M			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q3 2018		-$1.13M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.